The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Explanatory sequential mixed-methods comparison of oncology hospitalist vs general hospitalist teams for unplanned oncology patient admissions.
 
Megan Mullins
No Relationships to Disclose
 
Sanah Ladhani
No Relationships to Disclose
 
Emily Repasky
No Relationships to Disclose
 
Michael Wu
No Relationships to Disclose
 
Yunus Tarhan
No Relationships to Disclose
 
Bella Entigen
No Relationships to Disclose
 
Navid Sadeghi
No Relationships to Disclose
 
Jason Fleming
Stock and Other Ownership Interests - Bio-Path Holdings
Consulting or Advisory Role - Bio-Path Holdings; GlycosBio; MyCareGorithm; PanTher Therapeutics
Patents, Royalties, Other Intellectual Property - U.S. Application No. 15/780,799, based on International Application No. PCT/US2016/065763, entitled “Polymeric Drug Delivery Systems For Treatment of Disease,” by Chun Li et al.; In the Name of Board of Regents, The University of Texas System
 
Suzanne Conzen
Patents, Royalties, Other Intellectual Property - A GR antagonist methods patent owned by the University of Chicago that I am a co-Inventor on is licensed to Corcept Therapeutics
Travel, Accommodations, Expenses - Corcept Therapeutics
 
George Jackson
No Relationships to Disclose
 
Arthur Hong
Consulting or Advisory Role - Abbvie (I); Janssen (I); Novartis (I); UCB (I); UCB (I)
Speakers' Bureau - Abbvie (I); Janssen (I)
Research Funding - Abbvie (I); Amgen (I); Incyte (I); Janssen (I); Phoenicis (I)
Travel, Accommodations, Expenses - Abbvie (I); Janssen (I)